Saturday, October 31, 2026

NewJersey Resources Corporation And 3 Other Stocks Have Very High Payout Ratio

NewJersey Resources Corporation And 3 Other Stocks Have Very High Payout Ratio

Apache Corp. (APA), Blackrock MuniYield Fund (MYD), Pfizer (PFE) are the highest payout ratio stocks on this list.

Here's the data we've collected of stocks with a high payout ratio up to now. The payout ratio in itself isn't a promise of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. Apache Corp. (APA)

500% Payout Ratio

Apache Corporation, an independent energy company, explores for, develops, and produces natural gas, crude oil, and natural gas liquids (NGLs).

Volume

Today's last reported volume for Apache Corp. is 3653060 which is 47.98% below its average volume of 7022430.

According to Morningstar, Inc., the next dividend payment is on Jul 20, 2021, the estimated forward annual dividend rate is 0.1 and the estimated forward annual dividend yield is 0.46%.

Year-on-year quarterly revenue growth grew by 42.4%, now sitting on 4.97B for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 48.77%.

Volatility

Apache Corp.'s last day, week, and month's current volatility was 1.34%, 2.00%, and 1.84%, respectively.

Apache Corp.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.19% (day), 3.67% (last week), and 3.89% (last month), respectively.

Apache Corp.'s Stock Yearly Top and Bottom Value

Apache Corp.'s stock is valued at $21.47 at 23:23 EST, way under its 52-week high of $24.30 and way above its 52-week low of $7.45.

Apache Corp.'s Moving Average

Apache Corp.'s value is under its 50-day moving average of $21.85 and way higher than its 200-day moving average of $19.01.

2. Blackrock MuniYield Fund (MYD)

216.77% Payout Ratio

BlackRock MuniYield Fund, Inc. is a closed ended fixed income mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC.

Volume

Today's last reported volume for Blackrock MuniYield Fund is 46178 which is 21.47% below its average volume of 58804.

As maintained by Morningstar, Inc., the next dividend payment is on Jun 13, 2021, the estimated forward annual dividend rate is 0.67 and the estimated forward annual dividend yield is 4.46%.

Year-on-year quarterly revenue growth declined by 7.6%, now sitting on 43.7M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 2.04%.

Volatility

Blackrock MuniYield Fund 's last day, week, and month's current volatility was 0.27%, 0.25%, and 0.55%, respectively.

Blackrock MuniYield Fund 's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.33% (day), 0.58% (last week), and 0.98% (last month), respectively.

Blackrock MuniYield Fund 's Stock Yearly Top and Bottom Value

Blackrock MuniYield Fund 's stock is valued at $15.06 at 23:23 EST, under its 52-week high of $15.25 and way higher than its 52-week low of $13.12.

Blackrock MuniYield Fund 's Moving Average

Blackrock MuniYield Fund 's value is higher than its 50-day moving average of $14.99 and above its 200-day moving average of $14.56.

3. Pfizer (PFE)

92.17% Payout Ratio

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide.

Volume

Today's last reported volume for Pfizer is 16552000 which is 37.12% below its average volume of 26322700.

According to Morningstar, Inc., the next dividend payment is on Jul 28, 2021, the estimated forward annual dividend rate is 1.56 and the estimated forward annual dividend yield is 3.98%.

Pfizer's sales growth this year is anticipated to be 74.9% and a negative 15% for next year.

Year-on-year quarterly revenue growth grew by 44.6%, now sitting on 46.41B for the twelve trailing months.

Pfizer's sales growth is 58.9% for the current quarter and 62.5% for the next. The company's growth estimates for the current quarter and the next is 25.6% and 44.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.03%.

Volatility

Pfizer's last day, week, and month's current volatility was 1.02%, 0.42%, and 0.86%, respectively.

Pfizer's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.33% (day), 1.08% (last week), and 1.41% (last month), respectively.

Pfizer's Stock Yearly Top and Bottom Value

Pfizer's stock is valued at $39.73 at 23:23 EST, below its 52-week high of $43.08 and way above its 52-week low of $31.40.

Pfizer's Moving Average

Pfizer's worth is higher than its 50-day moving average of $39.41 and higher than its 200-day moving average of $37.27.

Previous days news about Pfizer (PFE)

Why Pfizer halted shipments of 1 of its top-selling products. According to The Motley Fool on Tuesday, 29 June, "Ironically, Pfizer has stopped shipping Chantix because of impurities found in the product that could cause cancer.", "Here's why Pfizer put the brakes on shipments of one of its top-selling products."

According to MarketWatch on Wednesday, 30 June, "Moderna has one authorized product, its two-dose, mRNA-based COVID-19 vaccine; the global success of its shot, along with BioNTech and Pfizer Inc.'s COVID-19 vaccine, has opened the door for broader interest in mRNA technology. "

4. NewJersey Resources Corporation (NJR)

46.13% Payout Ratio

New Jersey Resources Corporation, an energy services holding company, provides regulated gas distribution, and retail and wholesale energy services.

Volume

Today's last reported volume for NewJersey Resources Corporation is 262959 which is 41.41% below its average volume of 448785.

As maintained by Morningstar, Inc., the next dividend payment is on Jun 14, 2021, the estimated forward annual dividend rate is 1.33 and the estimated forward annual dividend yield is 3.35%.

NewJersey Resources Corporation's sales growth this year is anticipated to be 9% and 3.3% for next year.

Year-on-year quarterly revenue growth grew by 25.4%, now sitting on 1.96B for the twelve trailing months.

NewJersey Resources Corporation's sales growth for the next quarter is negative 6.4%. The company's growth estimates for the present quarter and the next is negative 83.3% and negative -89.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.83%.

Volatility

NewJersey Resources Corporation's last day, week, and month's current volatility was 0.21%, 1.04%, and 1.24%, respectively.

NewJersey Resources Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.48% (day), 1.97% (last week), and 2.18% (last month), respectively.

NewJersey Resources Corporation's Stock Yearly Top and Bottom Value

NewJersey Resources Corporation's stock is valued at $39.68 at 23:23 EST, way under its 52-week high of $44.41 and way above its 52-week low of $25.87.

NewJersey Resources Corporation's Moving Average

NewJersey Resources Corporation's value is under its 50-day moving average of $42.67 and higher than its 200-day moving average of $39.67.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com